Methyl 5-(3-bromophenyl)isoxazole-3-carboxylate, 95.0%, 1g

N-Boc-N-Ethyl-glycine, 97.0%, 500g

2-chloro-1,2-diphenylethan-1-one, 98.0%, 25g

(1-allyl-1H-benzimidazol-2-yl)methanol, 95.0%, 500mg

8-Bromo-11H-benzo[a]carbazole, 97%, 5g

1-ethyl-6-methyl-2-oxo-1,2-dihydro-3-pyridinecarbonitrile, 95.0%, 5g

GC capillary column ROTI®Cap-5, 25 m, 0.53 mm, 0.50 µm, 1 Piece(s)

3,4-Furandicarboxylic acid, 2,5-dihydro-, 3,4-dimethyl ester, 1g

3,5-Dimethyl-1-(1,1,2,2,2-pentafluoroethyl)benzene, 98.0%, 1g

4-Phenyl-1,3,4,5-tetrahydro-1,5-benzodiazepin-2-one, 96%, 250mg

Methyl 3-(2-methoxypyridin-4-yl)-3-oxopropanoate, 95%, 1g

4-Acetyl-2-nitro-phenol, 97.0%, 100g

(2E)-1-(4-bromophenyl)-3-(2,3,4-trimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g